Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04074668
What this trial is testing

Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance

Who this might be right for
Diabetic Kidney DiseaseType 1 DiabetesDiabetes+8 more
University of Colorado, Denver 58
Testing effectiveness (Phase 2)Study completedNCT03314935
What this trial is testing

INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Who this might be right for
Biliary Tract Cancer (BTC)Colorectal Cancer (CRC)Endometrial Cancer+3 more
Incyte Corporation 149
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Large-scale testing (Phase 3)Active Not RecruitingNCT05116189
What this trial is testing

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

Who this might be right for
Ovarian CancerCarcinoma, Ovarian EpithelialFallopian Tube Neoplasms
Merck Sharp & Dohme LLC 643
Post-approval studies (Phase 4)Study completedNCT00145340
What this trial is testing

Pioglitazone Treatment in Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Odense University Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT07811089
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OMS1620

Who this might be right for
Congenital Adrenal Hyperplasia (CAH)
OMass Therapeutics Australia Proprietary Ltd 84
Early research (Phase 1)Temporarily pausedNCT04711161
What this trial is testing

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

Who this might be right for
Ovarian Tumors
Green3Bio, Inc. 73
Early research (Phase 1)Not Yet RecruitingNCT07252661
What this trial is testing

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaThyroid Carcinoma, Medullary+6 more
AccSalus Biosciences, Inc. 40
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Early research (Phase 1)Study completedNCT03040362
What this trial is testing

Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration

Who this might be right for
Healthy
Eli Lilly and Company 8
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Early research (Phase 1)Study completedNCT02473627
What this trial is testing

A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

Who this might be right for
Healthy
Daiichi Sankyo 18
Early research (Phase 1)Study completedNCT04616027
What this trial is testing

STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT

Who this might be right for
Diabetes Mellitus, Type 2Renal ImpairmentHealthy
Pfizer 42
Early research (Phase 1)WithdrawnNCT01236586
What this trial is testing

RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
LymphomaBrain NeoplasmsSarcoma+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT05231746
What this trial is testing

HSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

Who this might be right for
Advanced Solid Tumor
STCube, Inc. 47
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Looking for participantsNCT07776626
What this trial is testing

Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Who this might be right for
Primary Hyperoxaluria Type 1PH1
YolTech Therapeutics Co., Ltd 9
Early research (Phase 1)Study completedNCT05468749
What this trial is testing

Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543

Who this might be right for
Renal Impairment
Concert Pharmaceuticals 16
Early research (Phase 1)Study completedNCT01588678
What this trial is testing

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 32
Early research (Phase 1)Study completedNCT01870115
What this trial is testing

Melatonin-Micronutrients for Osteopenia Treatment Study

Who this might be right for
OsteoporosisOsteopenia
Duquesne University 23
Next Page